732 Immune activation with plinabulin enhances anti-tumor response combining radiation with immune checkpoint blockade

• Vivek Subbiah,
• Huiying Sun,
• Siqing Fu,
• Lan Huang,
• Hui Gao,
• Steven H Lin,
• Ziyi Li,
• Evan Cohen,
• James Reuben,
• June Lu,
• Ken Lloyd,
• James Tonra

Affiliations

Vivek Subbiah

2MD Anderson Cancer Center, Houston, TX, USA

Huiying Sun

Department of Oncology, Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China

Siqing Fu

Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Lan Huang

Aff1 grid.412633.1Biotherapy Centerthe First Affiliated Hospital of Zhengzhou University Zhengzhou China

Hui Gao

1 Department of Oncology, General Hospital of Western Theatre Command, Chengdu, Sichuan, China

Steven H Lin

1The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Ziyi Li

1Dana-Farber Cancer Institute, Boston, MA, United States

Evan Cohen

1The University of Texas MD Anderson Cancer Center, Houston, TX, USA

James Reuben

1The University of Texas MD Anderson Cancer Center, Houston, TX, USA

June Lu

2BeyondSpring Pharmaceuticals, Inc., New York, NY, USA

Ken Lloyd

2BeyondSpring Pharmaceuticals, Inc., New York, NY, USA

James Tonra

2BeyondSpring Pharmaceuticals, Inc., New York, NY, USA